Addressing the Adult Soft Tissue Sarcoma Microenvironment with Intratumoral Immunotherapy

Table 2

Currently recruiting clinical trials of intratumoral immunotherapy in soft tissue sarcoma.

Treatment	Phase	ClinicalTrials.gov identifier
HSV-1 M002 (IT or IV)	I	NCT00931931
HSV-1 M002 + concurrent radiation	I/II	NCT02453191
HSV-1 M002 + pembrolizumab	II	NCT03069378
TVEC + preoperative radiation	I/II	NCT02453191
JX-594 + cyclophosphamide	I/II	NCT02630368
TTI-621	I	NCT02890368
INTUVAX	I	NCT02686944
Poly-ICLC	II	NCT01984892
Clostridium novyi-NT spores	I	NCT01924689